A new model of tiny human ovary organoids, or ovaroids, has been developed from stem cells, according to research presented ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no adverse effects ...

Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...

Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with fewer side effects.

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

A study from Australia shows that exercise improves outcomes of stem cell-derived dopaminergic neuron transplants in rats ...